As a global clinical-stage biotechnology company, our mission is the discovery and development of innovative cancer therapies across a spectrum of tumor types. Operating from R&D centers in New Jersey, U.S., and Hangzhou, China, we've brought together an experienced management team, curated a distinctive oncology pipeline, and formed partnerships with top pharmaceutical companies to accelerate drug discovery and development. We are committed to becoming an innovative biopharmaceutical company with a global footprint and strive to benefit patients worldwide.